Literature DB >> 27021771

History, Evolution, and Importance of Emergency Endovascular Treatment of Acute Ischemic Stroke.

Jessalyn K Holodinsky1, Amy Y X Yu2,3,4, Zarina A Assis5, Abdulaziz S Al Sultan2,4, Bijoy K Menon2,3,4,5,6, Andrew M Demchuk3,4,5,6, Mayank Goyal3,4,5,6, Michael D Hill2,3,4,5,6,7.   

Abstract

More than 800,000 people in North America suffer a stroke each year, with ischemic stroke making up the majority of these cases. The outcomes of ischemic stroke range from complete functional and cognitive recovery to severe disability and death; outcome is strongly associated with timely reperfusion treatment. Historically, ischemic stroke has been treated with intravenous thrombolytic agents with moderate success. However, five recently published positive trials have established the efficacy of endovascular treatment in acute ischemic stroke. In this review, we will discuss the history of stroke treatments moving from various intravenous thrombolytic drugs to intra-arterial thrombolysis, early mechanical thrombectomy devices, and finally modern endovascular devices. Early endovascular therapy failures, recent successes, and implications for current ischemic stroke management and future research directions are discussed.

Entities:  

Keywords:  Endovascular techniques; Ischemic stroke; Reperfusion; Thrombectomy; Thrombolytic therapy

Mesh:

Substances:

Year:  2016        PMID: 27021771     DOI: 10.1007/s11910-016-0646-5

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  95 in total

1.  Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial.

Authors:  Felipe de Los Ríos la Rosa; Jane Khoury; Brett M Kissela; Matthew L Flaherty; Kathleen Alwell; Charles J Moomaw; Pooja Khatri; Opeolu Adeoye; Daniel Woo; Simona Ferioli; Dawn O Kleindorfer
Journal:  Stroke       Date:  2012-03-22       Impact factor: 7.914

2.  Multiphase CT Angiography: A New Tool for the Imaging Triage of Patients with Acute Ischemic Stroke.

Authors:  Bijoy K Menon; Christopher D d'Esterre; Emmad M Qazi; Mohammed Almekhlafi; Leszek Hahn; Andrew M Demchuk; Mayank Goyal
Journal:  Radiology       Date:  2015-01-29       Impact factor: 11.105

3.  Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis.

Authors:  Alex Abou-Chebl; Christopher T Bajzer; Derk W Krieger; Anthony J Furlan; Jay S Yadav
Journal:  Stroke       Date:  2005-09-22       Impact factor: 7.914

4.  Time is brain--quantified.

Authors:  Jeffrey L Saver
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

5.  Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage.

Authors:  D W Newell; J M Eskridge; M R Mayberg; M S Grady; H R Winn
Journal:  J Neurosurg       Date:  1989-11       Impact factor: 5.115

6.  Subclavian artery stenosis treated by transluminal angioplasty: six cases.

Authors:  J P Galichia; A K Bajaj; D L Vine; R W Roberts
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

7.  A trial of imaging selection and endovascular treatment for ischemic stroke.

Authors:  Chelsea S Kidwell; Reza Jahan; Jeffrey Gornbein; Jeffry R Alger; Val Nenov; Zahra Ajani; Lei Feng; Brett C Meyer; Scott Olson; Lee H Schwamm; Albert J Yoo; Randolph S Marshall; Philip M Meyers; Dileep R Yavagal; Max Wintermark; Judy Guzy; Sidney Starkman; Jeffrey L Saver
Journal:  N Engl J Med       Date:  2013-02-08       Impact factor: 91.245

Review 8.  Classification of stroke subtypes.

Authors:  P Amarenco; J Bogousslavsky; L R Caplan; G A Donnan; M G Hennerici
Journal:  Cerebrovasc Dis       Date:  2009-04-03       Impact factor: 2.762

9.  Embolic strokes of undetermined source: the case for a new clinical construct.

Authors:  Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly
Journal:  Lancet Neurol       Date:  2014-04       Impact factor: 44.182

10.  2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  William J Powers; Colin P Derdeyn; José Biller; Christopher S Coffey; Brian L Hoh; Edward C Jauch; Karen C Johnston; S Claiborne Johnston; Alexander A Khalessi; Chelsea S Kidwell; James F Meschia; Bruce Ovbiagele; Dileep R Yavagal
Journal:  Stroke       Date:  2015-06-29       Impact factor: 10.170

View more
  5 in total

1.  Inter-rater reliability for assessing intracranial collaterals in patients with acute ischemic stroke: comparing 29 raters and an artificial intelligence-based software.

Authors:  Lennard Wolff; Jiahang Su; Derek Van Loon; Adriaan van Es; Pieter Jan van Doormaal; Charles Majoie; Wim van Zwam; Diederik Dippel; Aad van der Lugt; Theo van Walsum
Journal:  Neuroradiology       Date:  2022-05-24       Impact factor: 2.804

2.  Preclinical Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-ischemic Stroke Agent.

Authors:  Xin Tian; Hong-Meng Li; Jing-Yao Wei; Bing-Jie Liu; Yu-Hai Zhang; Gao-Ju Wang; Jun-Biao Chang; Hai-Ling Qiao
Journal:  Front Pharmacol       Date:  2016-08-18       Impact factor: 5.810

3.  Identification of variable lymphocyte receptors that can target therapeutics to pathologically exposed brain extracellular matrix.

Authors:  Benjamin J Umlauf; Paul A Clark; Jason M Lajoie; Julia V Georgieva; Samantha Bremner; Brantley R Herrin; John S Kuo; Eric V Shusta
Journal:  Sci Adv       Date:  2019-05-15       Impact factor: 14.136

4.  Intra-arterial Tirofiban in a Male Nonagenarian with Acute Ischemic Stroke: A Case Report.

Authors:  Xianhui Ding; Ao Gu; Qian Yang; Zhiming Zhou; Xiaolei Shi
Journal:  Open Life Sci       Date:  2019-12-31       Impact factor: 0.938

5.  Improving Awareness Could Transform Outcomes in Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 1].

Authors:  Benjamin M Davies; Oliver Mowforth; Helen Wood; Zahabiya Karimi; Iwan Sadler; Lindsay Tetreault; Jamie Milligan; Jamie R F Wilson; Sukhvinder Kalsi-Ryan; Julio C Furlan; Yoshiharu Kawaguchi; Manabu Ito; Carl Moritz Zipser; Timothy F Boerger; Alexander R Vaccaro; Rory K J Murphy; Mike Hutton; Ricardo Rodrigues-Pinto; Paul A Koljonen; James S Harrop; Bizhan Aarabi; Vafa Rahimi-Movaghar; Shekar N Kurpad; James D Guest; Jefferson R Wilson; Brian K Kwon; Mark R N Kotter; Michael G Fehlings
Journal:  Global Spine J       Date:  2022-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.